Minen, Mia T. http://orcid.org/0000-0002-4991-3703
Khanns, Dennique
Guiracocha, Jenny
Ehrlich, Annika
Khan, Fawad A.
Ali, Ashhar S.
Birlea, Marius
Singh, Niranjan N.
Peretz, Addie
Larry Charleston, I. V.
Funding for this research was provided by:
national center for complementary and integrative health (K 23 AT009706-01)
Article History
Received: 28 July 2021
Accepted: 30 December 2021
First Online: 8 February 2022
Declarations
:
: The NYU IRB determined that this was a quality study. There was implicit consent on the part of those who provided information about urgent care facility operations.
: The authors agree that the manuscript can be published.
: Dr. Charleston has received personal compensation for serving as a consultant for Allergan/AbbVie, Alder/Lundbeck, Biohaven, Satsuma and Teva; is on the advisory panel for Ctrl M Health (stock); received grant support from the Disparities in Headache Advisory Council; served as an Expert Witness for Vaccine Injury Compensation Program. He is a non-compensated associate editor for Headache: The Journal of Head and Face Pain and serves as a non-compensated Board Member-at-Large for the Alliance for Headache Disorders Advocacy. He reports no relevant conflict of interest for this manuscript.Ms. Ehrlich is on speaker bureau for Lilly and Abbvie. She has received consulting fees from Abbvie. She has served on advisory boards for Impel Neuropharma and Currax. She reports no relevant conflict of interest for this manuscript.Dr. Minen, Ms. Khanns, Ms. Guiracocha, Dr. Khan, Dr. Ali, Dr. Birlea, Dr. Singh, and Dr. Peretz report no conflicts.